Practice
The cardiovascular benefits of low-dosage acetylsalicylic acid
Priya Koilpillai and N. Sudhir Nishtala
CMAJ October 28, 2019 191 (43) E1194; DOI: https://doi.org/10.1503/cmaj.191037
Priya Koilpillai
Departments of Internal Medicine (Koilpillai) and of Cardiac Sciences (Nishtala), University of Calgary, Calgary, Alta.
MDN. Sudhir Nishtala
Departments of Internal Medicine (Koilpillai) and of Cardiac Sciences (Nishtala), University of Calgary, Calgary, Alta.
MD![Loading Loading](https://www.cmaj.ca/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data supplements
Podcast
Related Articles
In this issue
Article tools
The cardiovascular benefits of low-dosage acetylsalicylic acid
Priya Koilpillai, N. Sudhir Nishtala
CMAJ Oct 2019, 191 (43) E1194; DOI: 10.1503/cmaj.191037
Jump to section
- Article
- Acetylsalicylic acid has established benefit in the secondary prevention of cardiovascular disease
- The benefit of ASA in the primary prevention of cardiovascular disease is offset by potential bleeding risks
- Patients with diabetes, despite their increased cardiovascular risk, have questionable benefit from ASA used for primary prevention
- Perioperative use of ASA in noncardiac surgery is unlikely to reduce the risk of myocardial infarction or venous thromboembolism
- Acetylsalicylic acid should be used for patients with myocardial injury or ischemia after noncardiac surgery
- Footnotes
- References
- Figures & Tables
- Related Content
- Responses
- Metrics
Podcast